Mannatech, Incorporated provides wellness solutions. The company develops, markets, and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It markets its products through network marketing channels in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific. The company was founded in 1993 and is headquartered in Coppell, Texas.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone972-471-7400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$176.70 million
Profitability
Miscellaneous
Employees250
OptionableNot Optionable
Mannatech (NASDAQ:MTEX) Frequently Asked Questions
What is Mannatech's stock symbol?
Mannatech trades on the NASDAQ under the ticker symbol "MTEX."
How often does Mannatech pay dividends? What is the dividend yield for Mannatech?
Mannatech announced a quarterly dividend on Wednesday, November 14th. Shareholders of record on Thursday, December 6th will be paid a dividend of $0.50 per share on Thursday, December 27th. This represents a $2.00 annualized dividend and a yield of 10.49%. The ex-dividend date is Wednesday, December 5th. View Mannatech's Dividend History.
How will Mannatech's stock buyback program work?
Mannatech announced that its Board of Directors has initiated a share repurchase plan on Wednesday, November 14th 2018, which permits the company to repurchase $500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 1.3% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.
How were Mannatech's earnings last quarter?
Mannatech, Inc. (NASDAQ:MTEX) announced its earnings results on Tuesday, November, 7th. The company reported $0.50 earnings per share (EPS) for the quarter. The firm had revenue of $42 million for the quarter. Mannatech had a negative net margin of 3.43% and a negative return on equity of 2.51%. View Mannatech's Earnings History.
When is Mannatech's next earnings date?
Has Mannatech been receiving favorable news coverage?
News articles about MTEX stock have trended neutral on Wednesday, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Mannatech earned a news impact score of 0.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near future.
Who are some of Mannatech's key competitors?
Some companies that are related to Mannatech include Mediwound (MDWD), Natural Alternatives International (NAII), Pharmacyte Biotech (PMCB), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), FitLife Brands (FTLF), Tauriga Sciences (TAUG), True Drinks (TRUU), Nutra Pharma (NPHC), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE), Beleave (BE) and ImmuDyne (IMMD).
Who are Mannatech's key executives?
Mannatech's management team includes the folowing people:
- Mr. Alfredo Bala, CEO & Pres (Age 58)
- Mr. Joel R. Bikman, Chief Operating & Marketing Officer (Age 46)
- Mr. David A. Johnson, Chief Financial Officer (Age 49)
- Ms. Erin Kemmler Barta, Gen. Counsel & Corp. Sec. (Age 49)
- Mr. Landen Granvel Fredrick, Chief Global Sales Officer & Pres of North America (Age 46)
Who are Mannatech's major shareholders?
Mannatech's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.32%), Quinn Opportunity Partners LLC (0.84%), Northern Trust Corp (0.43%) and Advisor Group Inc. (0.07%). Company insiders that own Mannatech stock include Alfredo Bala, Eric W Schrier, Kevin Andrew Robbins, Larry A Jobe, Linda K Ferrell and Robert Toth. View Institutional Ownership Trends for Mannatech.
Which institutional investors are selling Mannatech stock?
Which institutional investors are buying Mannatech stock?
MTEX stock was purchased by a variety of institutional investors in the last quarter, including Advisor Group Inc. and BlackRock Inc.. Company insiders that have bought Mannatech stock in the last two years include Eric W Schrier, Kevin Andrew Robbins, Larry A Jobe, Linda K Ferrell and Robert Toth. View Insider Buying and Selling for Mannatech.
How do I buy shares of Mannatech?
Shares of MTEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mannatech's stock price today?
One share of MTEX stock can currently be purchased for approximately $19.06.
How big of a company is Mannatech?
Mannatech has a market capitalization of $45.36 million and generates $176.70 million in revenue each year. Mannatech employs 250 workers across the globe.
What is Mannatech's official website?
How can I contact Mannatech?
Mannatech's mailing address is 1410 LAKESIDE PARKWAY SUITE 200, FLOWER MOUND TX, 75028. The company can be reached via phone at 972-471-7400 or via email at [email protected]
MarketBeat Community Rating for Mannatech (NASDAQ MTEX)
MarketBeat's community ratings are surveys of what our community members think about Mannatech and other stocks. Vote "Outperform" if you believe MTEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTEX will underperform the S&P 500 over the long term. You may vote once every thirty days.
